Yoshifumi Komoike Selected Research

Yoshifumi Komoike Research Topics

Disease

55	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
18	Neoplasms (Cancer) 08/2020 - 01/2002
13	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2004
3	Lymphatic Metastasis 02/2016 - 08/2007
2	Neoplasm Micrometastasis 05/2017 - 08/2007
2	Brain Neoplasms (Brain Tumor) 12/2013 - 11/2013
1	Disease Progression 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 08/2020
1	Solitary Pulmonary Nodule 08/2020
1	Second Primary Neoplasms (Neoplasms, Second) 02/2019
1	Carcinosarcoma 01/2019
1	Hyperaldosteronism (Conn Syndrome) 12/2017
1	Spontaneous Fractures (Pathological Fracture) 09/2017
1	Pain (Aches) 09/2017
1	Spinal Cord Compression 09/2017
1	Arthralgia (Joint Pain) 02/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2013
1	Carcinoma (Carcinomatosis) 01/2010
1	Neutropenia 01/2010
1	Wounds and Injuries (Trauma) 01/2009
1	Margins of Excision 01/2006
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2004
1	Lobular Carcinoma 01/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2002

Drug/Important Bio-Agent (IBA)

14	Hormones (Hormone)IBA 01/2022 - 01/2006
7	Estrogen ReceptorsIBA 09/2018 - 01/2004
4	AnthracyclinesIBA 10/2019 - 01/2010
4	Epirubicin (Ellence)FDA LinkGeneric 09/2017 - 01/2002
3	human ERBB2 proteinIBA 01/2021 - 06/2013
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 11/2008
3	Messenger RNA (mRNA)IBA 02/2016 - 08/2007
3	Nucleic AcidsIBA 02/2016 - 08/2007
3	Anastrozole (Arimidex)FDA LinkGeneric 02/2016 - 01/2011
3	ErbB Receptors (EGF Receptor)IBA 06/2015 - 01/2013
3	Radioisotopes (Radionuclides)IBA 01/2005 - 01/2002
3	Coloring Agents (Dyes)IBA 01/2005 - 01/2002
2	Capecitabine (Xeloda)FDA Link 08/2021 - 12/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 11/2008
2	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2010
2	Circulating Tumor DNAIBA 08/2020 - 09/2018
2	eribulin FDA Link 10/2019 - 12/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2017 - 06/2014
2	Biomarkers (Surrogate Marker)IBA 11/2013 - 01/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2013 - 01/2010
2	Tamoxifen FDA LinkGeneric 01/2011 - 08/2010
2	Aromatase InhibitorsIBA 01/2010 - 11/2009
2	Keratin-19 (Keratin 19)IBA 04/2009 - 08/2007
1	Bevacizumab (Avastin)FDA Link 08/2021
1	pertuzumabIBA 01/2021
1	taxaneIBA 10/2019
1	Mitogen-Activated Protein KinasesIBA 02/2019
1	TOR Serine-Threonine KinasesIBA 02/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2019
1	Ado-Trastuzumab EmtansineIBA 09/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2017
1	pirarubicinIBA 09/2017
1	Fluorouracil (Carac)FDA LinkGeneric 09/2017
1	Immunologic Factors (Immunomodulators)IBA 09/2017
1	Zoledronic Acid (Zometa)FDA Link 09/2017
1	Keratins (Keratin)IBA 02/2016
1	130-nm albumin-bound paclitaxelIBA 06/2015
1	S 1 (combination)IBA 06/2015
1	MethyltransferasesIBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	Phenobarbital (Luminal)FDA Link 06/2014
1	Lapatinib (GW572016)FDA Link 12/2013
1	TeaIBA 12/2013
1	Coffee FDA Link 12/2013
1	ferric oxide (iron oxide)IBA 11/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	antineoplaston A10 (A 10)IBA 08/2010
1	Serine (L-Serine)FDA Link 01/2010
1	Estrogen Receptor alphaIBA 01/2010
1	Estrogen Receptor betaIBA 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2006

Therapy/Procedure

16	Therapeutics 08/2021 - 11/2002
10	Segmental Mastectomy (Lumpectomy) 01/2019 - 01/2002
10	Radiotherapy 11/2014 - 11/2002
9	Lymph Node Excision (Lymph Node Dissection) 05/2017 - 01/2002
7	Drug Therapy (Chemotherapy) 09/2017 - 11/2008
6	Mastectomy (Mammectomy) 01/2010 - 01/2002
5	Neoadjuvant Therapy 01/2010 - 01/2002
3	Adjuvant Chemotherapy 09/2017 - 01/2010
1	Aftercare (After-Treatment) 08/2020
1	Mammaplasty (Breast Reconstruction) 01/2019
1	Duration of Therapy 09/2017
1	EC regimen 09/2017
1	Activities of Daily Living (ADL) 02/2016
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2008
1	Gamma Cameras (Gamma Camera) 01/2005
1	Operative Surgical Procedures 01/2004
1	Intradermal Injections 02/2003